Cystectomy Remains Standard of Care Following Neoadjuvant Therapy in Patients with Muscle-Invasive Bladder Cancer. // European Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0302283826021718?dgcid=rss_sd_all
Cystectomy Remains Standard of Care Following Neoadjuvant Therapy in Patients with Muscle-Invasive Bladder Cancer. European Urology. https://www.sciencedirect.com/science/article/pii/S0302283826021718?dgcid=rss_sd_all
“Cystectomy Remains Standard of Care Following Neoadjuvant Therapy in Patients with Muscle-Invasive Bladder Cancer.” European Urology.
@article{article45520,
title = {Cystectomy Remains Standard of Care Following Neoadjuvant Therapy in Patients with Muscle-Invasive Bladder Cancer},
journal = {European Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0302283826021718?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...